Pioneering The Next Generation of Solid Tumor T Cell Immunotherapies
Maverick Therapeutics, Inc. has been acquired by Takeda Pharmaceutical Company Limited. To learn more about the acquisition, visit Takeda’s website here. To continue to Maverick’s website, please dismiss this notice.
Close
Who We Are
Focusing on improving the lives of patients with solid tumor cancers.
Our Science
Developing the most mature bispecific T cell engaging platform in its class.
